TokenPost·
Pathos AI Raises $237 Million in Series E at About a $3 Billion Valuation
$237M
Series E raise
Bristol Myers Squibb led the round. Pathos AI plans to expand Foundry and advance four cancer drug candidates in clinical development.
More news
- TokenPostFrontier Token Falls 33.62% in 30 Minutes to $0.010367
- TokenPostBackpack CEO Says Company Has Never Sold Token Warrants
- TokenPostOil India Well Test Peaks at 200,000 Standard Cubic Meters of Gas per Day
- TokenPostRingCentral Shares Gain 5% as Analysts Raise Price Targets
- TokenPostMMG Offers Supply Guarantee as EU Reviews Anglo American Nickel Deal
- TokenPostSteele Bancorp, Inc. Posts 60% Drop in Third-Quarter Profit